If I made (a poor technical) reference to biphenotypic acute leukaemia t-cell with no inversions or over-expressions I suspect you are one of but a few who would understand my interest in CYP amongst one or two other bio-tech companies.
If I made (a poor technical) reference to biphenotypic acute...
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.025(8.47%) |
Mkt cap ! $48.50M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 27.0¢ | $444 | 1.643K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 1449 | 1 |
View Market Depth
| Last trade - 10.28am 01/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |